News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

G1 Therapeutics (GTHX) Reports Second Quarter 2017 Financial Results And Recent Operational Highlights



8/9/2017 1:02:11 PM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
RESEARCH TRIANGLE PARK, N.C., Aug. 09, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a clinical-stage oncology company, today reported financial results for the quarter ended June 30, 2017, and provided an update on its corporate activities and product pipeline.

“The second quarter of 2017 proved to be transformational for G1, as we made further progress with our oncology drug development programs and raised $107.1 million in net proceeds in our successful initial public offering,” said Mark Velleca, MD, PhD, Chief Executive Officer of G1.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES